Who founded Werewolf Therapeutics?

Werewolf Therapeutics was founded by Daniel J. Hicklin, Luke Evnin, Daniel Hicklin in 2017.

Who are Werewolf Therapeutics's investors?

Werewolf Therapeutics's investors include DC Investment Partners, K2 HealthVentures, Longwood Fund, MPM BioImpact, RA Capital, Taiho Ventures, LLC.

How much funding has Werewolf Therapeutics raised?

Werewolf Therapeutics has disclosed $128.2M raised across 2 rounds.

Where is Werewolf Therapeutics headquartered?

Werewolf Therapeutics is headquartered in Watertown, US.

Werewolf Therapeutics

Watertown, US · Founded 2017 · Delaware corporation · 6 known investors

Find your way into Werewolf Therapeutics

122 people in our graph share verified history with the Werewolf Therapeutics team — schools, employers, funds. One of them is your warm intro.

Jim Breyerunlockedknows Luke Evnin · together at Accel Partners (overlapped)

knows the team · via Mpmcapital

knows the team · via Accel Partners

×8knows the team · via MPM BioImpact

knows the team · via Maverick Therapeutics

Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer. The company focuses on leveraging immune modulation and innovative therapeutic approaches in oncology.

Biotech Healthtech Medical Devices

Founders & leadership

Werewolf Therapeutics was founded in 2017 by Daniel J. Hicklin, Luke Evnin, and Daniel Hicklin.

Daniel J. HicklinFounder, President, Chief Executive Officer, and Board memberManaging Partner at MPM Capital

Luke Evnin in 𝕏Co-founder, Board member (Chairman)Advisor at MPM BioImpact

Daniel HicklinCo-founderManaging Partner at MPM Capital

David CordoExecutive

Alon LazarusNamed on SEC filing

Board

Christoph WestphalBoard directorCo-Founder & General Partner at Longwood Fund

Briggs Morrison inBoard MemberEntrepreneur Partner at MPM BioImpact

Sakae AsanumaBoard directorPresident and CEO at Taiho Ventures, LLC

Investors · 6

DC Investment PartnersMcLean · $10M

K2 HealthVenturesBoston · $10M – $100M

Longwood FundBoston

MPM BioImpactBoston · $1M – $15M

RA CapitalBostonvia Derek DiRocco · board

Taiho Ventures, LLCMenlo Park

Reported raises · per SEC filings

Form D private placements

$128.2M disclosed across 2 rounds · 2019–2020

▶$72.1MraisedJan 2021 · 19 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Luke EvninDirector
Briggs MorrisonDirector
Daniel HicklinExecutive Officer, Director
Sakae AsanumaDirector
Alon LazarusDirector
Elise WangDirector
David CordoExecutive Officer
Derek DiRoccoDirector

Offering amount: $72.1M
Amount sold: $72.1M
First sale: Dec 2020
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$56.2MraisedAug 2020 · 10 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Luke EvninDirector
Daniel HicklinExecutive Officer, Director
Alon LazarusDirector
David CordoExecutive Officer
Christoph WestphalDirector
Briggs MorrisonDirector
Sakae AsanumaDirector

Offering amount: $56.2M
Amount sold: $56.2M
First sale: Aug 2019
Incorporated: Corporation, Delaware, 2017
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Werewolf Therapeutics went on to found or lead other companies.

Briggs MorrisonDirectorFounded Crossbow Therapeutics +1 Luke EvninCo-founder, Board member (Chairman)Founded Mpmcapital

Competitors · 5

by search overlap

Perplexity14 shared keywordsAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.

Seeking Alpha12 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.

StockTwits12 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.

Simply Wall St12 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.

Grey Wolf Therapeutics11 shared keywordsGreywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.

Companies competing with Werewolf Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Acquisitions · 1

Early investors' stakes continue via these deals

Ambros Therapeutics

Ambros Therapeutics is a clinical-stage biotech developing neridronate, a bisphosphonate already approved in Italy, as a treatment for Complex Regional Pain Syndrome Type 1 (CRPS-1).

Frequently asked questions

What does Werewolf Therapeutics do?: Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer. The company focuses on leveraging immune modulation and innovative therapeutic approaches in oncology.
Who founded Werewolf Therapeutics?: Werewolf Therapeutics was founded by Daniel J. Hicklin, Luke Evnin, Daniel Hicklin in 2017.
Who are Werewolf Therapeutics's investors?: Werewolf Therapeutics's investors include DC Investment Partners, K2 HealthVentures, Longwood Fund, MPM BioImpact, RA Capital, Taiho Ventures, LLC.
How much funding has Werewolf Therapeutics raised?: Werewolf Therapeutics has disclosed $128.2M raised across 2 rounds.
Where is Werewolf Therapeutics headquartered?: Werewolf Therapeutics is headquartered in Watertown, US.